Many patients with overweight or obesity discontinue glucagon-like peptide-1 receptor agonist therapy within one year.
Electronic symptom monitoring with patient-reported outcomes meaningfully improves clinical outcomes for cancer treatment ...
Federal funding for medical research has dropped by $1 billion this year, raising alarm among universities, medical centers, and lawmakers.